532 related articles for article (PubMed ID: 25600868)
1. The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance.
Warrier M; Shih DM; Burrows AC; Ferguson D; Gromovsky AD; Brown AL; Marshall S; McDaniel A; Schugar RC; Wang Z; Sacks J; Rong X; Vallim TA; Chou J; Ivanova PT; Myers DS; Brown HA; Lee RG; Crooke RM; Graham MJ; Liu X; Parini P; Tontonoz P; Lusis AJ; Hazen SL; Temel RE; Brown JM
Cell Rep; 2015 Jan; 10(3):326-338. PubMed ID: 25600868
[TBL] [Abstract][Full Text] [Related]
2. Trimethylamine
Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
4. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
[TBL] [Abstract][Full Text] [Related]
5. Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.
Iglesias-Carres L; Chadwick-Corbin SA; Sweet MG; Neilson AP
J Nutr Biochem; 2023 Oct; 120():109428. PubMed ID: 37549832
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis.
Schugar RC; Brown JM
Curr Opin Lipidol; 2015 Oct; 26(5):426-31. PubMed ID: 26218418
[TBL] [Abstract][Full Text] [Related]
7. Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.
Petriello MC; Hoffman JB; Sunkara M; Wahlang B; Perkins JT; Morris AJ; Hennig B
J Nutr Biochem; 2016 Jul; 33():145-53. PubMed ID: 27155921
[TBL] [Abstract][Full Text] [Related]
8. FMO3 and its metabolite TMAO contribute to the formation of gallstones.
Chen Y; Weng Z; Liu Q; Shao W; Guo W; Chen C; Jiao L; Wang Q; Lu Q; Sun H; Gu A; Hu H; Jiang Z
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2576-2585. PubMed ID: 31251986
[TBL] [Abstract][Full Text] [Related]
9. Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.
Anwar S; Bhandari U; Panda BP; Dubey K; Khan W; Ahmad S
J Pharm Biomed Anal; 2018 Sep; 159():100-112. PubMed ID: 29980011
[TBL] [Abstract][Full Text] [Related]
10. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.
Fennema D; Phillips IR; Shephard EA
Drug Metab Dispos; 2016 Nov; 44(11):1839-1850. PubMed ID: 27190056
[TBL] [Abstract][Full Text] [Related]
11. Hif-1α expression targets the TMA/Fmo3/TMAO axis to participate in gallbladder cholesterol stone formation in individuals living in plateau regions.
Luo M; Chen P; Tian Y; Rigzin N; Sonam J; Shang F; Tai C; Li T; Sang H
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167188. PubMed ID: 38657913
[TBL] [Abstract][Full Text] [Related]
12. Trimethylamine-N-oxide and cerebral stroke risk: A review.
Dolkar P; Deyang T; Anand N; Rathipriya AG; Hediyal TA; Chandrasekaran V; Krishnamoorthy NK; Gorantla VR; Bishir M; Rashan L; Chang SL; Sakharkar MK; Yang J; Chidambaram SB
Neurobiol Dis; 2024 Mar; 192():106423. PubMed ID: 38286388
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of trimethylamine-N-oxide in the pathogenesis of atherosclerosis].
He H; Lian X; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):986-990. PubMed ID: 28872093
[TBL] [Abstract][Full Text] [Related]
14. Genetic Deficiency of Flavin-Containing Monooxygenase 3 ( Fmo3) Protects Against Thrombosis but Has Only a Minor Effect on Plasma Lipid Levels-Brief Report.
Shih DM; Zhu W; Schugar RC; Meng Y; Jia X; Miikeda A; Wang Z; Zieger M; Lee R; Graham M; Allayee H; Cantor RM; Mueller C; Brown JM; Hazen SL; Lusis AJ
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1045-1054. PubMed ID: 31070450
[TBL] [Abstract][Full Text] [Related]
15. Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation.
Kim SJ; Bale S; Verma P; Wan Q; Ma F; Gudjonsson JE; Hazen SL; Harms PW; Tsou PS; Khanna D; Tsoi LC; Gupta N; Ho KJ; Varga J
iScience; 2022 Jul; 25(7):104669. PubMed ID: 35856022
[TBL] [Abstract][Full Text] [Related]
16. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis.
Shih DM; Wang Z; Lee R; Meng Y; Che N; Charugundla S; Qi H; Wu J; Pan C; Brown JM; Vallim T; Bennett BJ; Graham M; Hazen SL; Lusis AJ
J Lipid Res; 2015 Jan; 56(1):22-37. PubMed ID: 25378658
[TBL] [Abstract][Full Text] [Related]
17. Flavin-Containing Monooxygenase 3 (FMO3) Is Critical for Dioxin-Induced Reorganization of the Gut Microbiome and Host Insulin Sensitivity.
Massey W; Osborn LJ; Banerjee R; Horak A; Fung KK; Orabi D; Chan ER; Sangwan N; Wang Z; Brown JM
Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448550
[TBL] [Abstract][Full Text] [Related]
18. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis.
Liang X; Zhang Z; Lv Y; Tong L; Liu T; Yi H; Zhou X; Yu Z; Tian X; Cui Q; Yang J; Gong P; Zhang L
Nutrition; 2020; 79-80():110941. PubMed ID: 32858376
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variant in Flavin-Containing Monooxygenase 3 Alters Lipid Metabolism in Laying Hens in a Diet-Specific Manner.
Wang J; Long C; Zhang H; Zhang Y; Wang H; Yue H; Wang X; Wu S; Qi G
Int J Biol Sci; 2016; 12(11):1382-1393. PubMed ID: 27877090
[TBL] [Abstract][Full Text] [Related]
20. Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD.
Li X; Hong J; Wang Y; Pei M; Wang L; Gong Z
Front Mol Biosci; 2021; 8():733507. PubMed ID: 34660695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
